Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYGenmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) AmyloidosisPREV STORYBiomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update